Genomic organization of the flt-1 gene encoding for Vascular Endothelial Growth Factor (VEGF) Receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors

Gene

Volumn 208, Issue 2, 1998, Pages 297-305

  Kondo, Kunio ^a   Hiratsuka, Sachie ^a   Subbalakshmi, Easwaran ^a   Matsushime, Hitoshi ^a,b   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kamakura 247   (Japan)

Author keywords

7 Ig (flt) family; fms like tyrosine kinase 1; sFlt 1

Indexed keywords

IMMUNOGLOBULIN; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; DNA SEQUENCE; EXON; EXTRACELLULAR SPACE; GENE DELETION; GENE INSERTION; GENE LOCATION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN CELL; INTRON; MOLECULAR EVOLUTION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RESTRICTION MAPPING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; ENDOTHELIAL GROWTH FACTORS; EVOLUTION, MOLECULAR; EXONS; GENE LIBRARY; HUMANS; INTRONS; LUNG; LYMPHOKINES; MICE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RESTRICTION MAPPING; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032570774     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00006-7     Document Type: Article

References (34)

1. Barleon B., Sozzani S., Zhou D., Weich H.A., Martovani A., Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:1996;3336-3343.
2. Bourgois A. Evidence for an ancestral immunoglobulin gene coding for half a domain. Immunochemistry. 12:1975;873-876.
3. Clauss M., Weicht H., Breier G., Knies U., Rockl W., Waltenberger J., Risau W. Vascular permeability factor: a tumor-derived polypeptide that induced endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Biol. Chem. 271:1996;17629-17634.
4. Coussens L., Van Beveren C., Smith D., Chen E., Mitchell R.L., Isacke C.K., Verma I.M., Ullrich A. Structural organization of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature. 320:1986;277-280.
5. De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
6. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 18:1997;4-25.
7. Finnerty H., Kelleher K., Morris G.E., Bean K., Merberg D.M., Kriz R., Morris J.C., Sookdeo H., Turner K.J., Wood C.R. Molecular cloning of murine FLT and FLT4. Oncogene. 8:1993;2293-2298.
8. Fong G.-H., Rossant J., Gertsentein M., Breitman M.L. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
9. Giebel L.B., Strunk K.M., Holmes S.A., Spritz R.A. Organization and nucleotide sequence of the human Kit (mast/stem cell growth factor receptor) proto-oncogene. Oncogene. 7:1992;2207-2217.
10. Gilbert W. The exon theory of genes. Cold Spring Harbor Symp. Quant. Biol. 52:1987;901-905.
11. Gokkel E., Grossman Z., Ramot B., Yarden Y., Rechavi G., Givol D. Structural organization of the murine c-kit proto-oncogene. Oncogene. 7:1992;1423-1429.
12. Hampe A., Shamoon B., Gobet M., Sherr C., Galibert F. Nucleotide sequence and structural organization of the human fms proto-oncogene. Oncogene Res. 7:1989;9-17.
13. Ikeda T., Wakiya K., Shibuya M. Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor. Growth Factors. 13:1996;151-162.
14. Kaipainen A., Korhonen J., Pajusola K., Aprelikova O., Persico M.G., Terman B.I., Alitalo K. The related FLT4, FLT1, and KDR receptor tyrosine kinase show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178:1993;2077-2088.
15. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl Acad. Sci. USA. 90:1993;10705-10709.
16. Kwiatowski J., Krawczyk M., Kornacki M., Bailey K., Ayala F. Evidence of the exon theory of genes derived from the triose-phosphate isomerase gene. Proc. Natl Acad. Sci. USA. 92:1995;8503-8506.
17. Logston J.M. Jr., Tyshenko M.G., Dixon C., -Jafari J.D., Walker V.K., Palmer J.K. Seven newly discovered intron positions in the triose-phosphate isomerase gene. Proc. Natl Acad. Sci. USA. 92:1995;8507-8511.
18. Matsushime H., Shibuya M. Tissue-specific expression of rat c-ros-1 gene and partial structural similarity of its predicted products with sev protein of Drosophila melanogaster. J. Virol. 64:1990;2117-2125.
19. Mustonen T., Alitalo K. Endothelial receptor tyrosine kinase involved in angiogenesis. J. Cell Biol. 129:1995;895-898.
20. Padgett R.A., Grabowski P.J., Konarska M.M., Seiler S., Sharp P. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1986;1119-1150.
21. Pajusola K., Aprelikova O., Armstrong E., Morris S., Alitalo K. Two human flt4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene. 8:1993;2931-2937.
22. Park J.E., Chen H.H., Winer J., Houck K.A., Ferrara N. Placenta growth factor. J. Biol. Chem. 269:1994;25646-25654.
23. Peters K.G., De Vries C., Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA. 90:1993;8915-8919.
24. Qiu F., Ray P., Brown K., Barker P.E., Jhanwar S., Ruddle F.H., Besmer P. Primary structure of c-kit; relationship with the CSF-1/PDGF receptor kinase family oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 7:1988;1003-1011.
25. Rosnet O., Stephenson D., Mattei M.G., Marchetto S., Shibuya M., Chapman V.M., Birnbaum D. Close physical linkage of the flt-1 and flt-3 gene on chromosome 13 in man and chromosome 5 in mouse. Oncogene. 8:1993;173-179.
26. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA. 74:1977;5463-5467.
27. Sawano A., Takahashi T., Yamaguchi S., Aonuma T., Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth and Differentiation. 7:1996;213-221.
28. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.-F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in FLK-1-deficient mice. Nature. 376:1995;62-66.
29. Shibuya M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res. 67:1995;281-316.
30. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524.
31. Wakiya K., Begue A., Stehelin D., Shibuya M. A cAMP response element and ets motif are involved in the transcriptional regulation on flt-1 tyrosine kinase (Vascular endothelial growth factor receptor 1) gene. J. Biol. Chem. 271:1996;30823-30828.
32. Williams A., Barclay A. The immunoglobulin superfamily - domains for cell surface recognition. Annu. Rev. Immunol. 6:1988;381-404.
33. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and flt tyrosine kinase receptor family (flt-1 and KDR/flk-1). Oncogene. 9:1994;2683-2690.
34. Yarden Y., Kuang W.J., Yang-Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U., Ullrich A. Human proto-oncogene c-kit; a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6:1987;3341-3351.